Royalty War

New York University has filed a lawsuit against Pfizer in an effort to collect royalty payments it says the pharma firm owes it for a lung cancer drug and diagnostic kit, according to PharmaLive.

NYU says Pfizer owes royalties on a drug called Xalkori, a receptor tyrosine kinase inhibitor that FDA cleared two years ago to treat non-small cell lung cancer.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.